Stay updated with breaking news from Neurometrix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of NeuroMetrix (NASDAQ:NURO – Free Report) in a research note issued to investors on Friday morning. The firm issued a sell rating on the medical device company’s stock. NeuroMetrix Price Performance Shares of NASDAQ NURO opened at $4.70 on Friday. NeuroMetrix has a 1 year low of $2.70 and a […] ....
StockNews.com began coverage on shares of NeuroMetrix (NASDAQ:NURO – Free Report) in a report published on Friday. The firm issued a sell rating on the medical device company’s stock. NeuroMetrix Trading Up 0.7 % NASDAQ:NURO opened at $4.44 on Friday. NeuroMetrix has a twelve month low of $2.70 and a twelve month high of $11.55. […] ....
StockNews.com assumed coverage on shares of NeuroMetrix (NASDAQ:NURO – Free Report) in a research note released on Friday morning. The firm issued a sell rating on the medical device company’s stock. NeuroMetrix Price Performance NURO opened at $4.44 on Friday. The stock’s 50-day moving average price is $3.89 and its 200 day moving average price […] ....
NeuroMetrix, Inc. (NASDAQ:NURO – Get Free Report) saw a significant decrease in short interest in March. As of March 15th, there was short interest totalling 23,200 shares, a decrease of 46.0% from the February 29th total of 43,000 shares. Based on an average daily volume of 53,400 shares, the days-to-cover ratio is presently 0.4 days. […] ....
NeuroMetrix (NASDAQ:NURO – Get Free Report) posted its quarterly earnings results on Thursday. The medical device company reported ($1.43) earnings per share (EPS) for the quarter, Zacks reports. The company had revenue of $1.32 million during the quarter. NeuroMetrix had a negative net margin of 110.64% and a negative return on equity of 30.93%. NeuroMetrix […] ....